Ann: Solagran Successful in Federal Court , page-7

re: Ann: SLA: Solagran Successful in Federal ... SR you if SLA are quiet [well no quiet lately but they have put out some very ambitious info in the past] - then you appear to be making enough noise on Big V's behalf. [Who may have paid 4x over current value for oppies - but only took-up half the tranche from memory so lets not fudge the director take up issue, as if you go that track you would then have to include shares in lieu of salary factor].

You keep bringing up the chicken feed thing - it was never going to happen in Australia due to the residuals issue - meaning both APEVMA and TGA approvals in a very very complex testing program - looooooong time lines and big bucks. Why did SLA not know this?
The companion pet and route was the most viable path for Bioeffectives husbandry applications - but SLA management did not see this.

Now if SLA were to dump today they would have turned their $2.7M BPOs into about $270K - yep a 10 bagger in reverse. So looking at that scenario from the outside a new investor would have to question the management skills behind the moves.

So as a BPO holder I'm not impressed with this outcome. As a SLA holder - maybe even less so.

These are both bottom draw stuff now [except maybe for those sitting on the 20M sub 1c orders]